Quarterly report · Q3
8095.TEDINET S100PC1Z
Period2021-12-01 → 2022-08-31
Filed2022-10-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥36.9bn | 2021-12-01 → 2022-08-31 | Cons. | Net sales |
| Revenue | ¥72.3bn | 2020-12-01 → 2021-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥53.7bn | 2020-12-01 → 2021-08-31 | Cons. | Net sales |
| Operating income | ¥426m | 2021-12-01 → 2022-08-31 | Cons. | Operating income |
| Operating income | ¥2.0bn | 2020-12-01 → 2021-08-31 | Cons. | Operating income |
| Ordinary income | ¥517m | 2021-12-01 → 2022-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.4bn | 2020-12-01 → 2021-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.0bn | 2020-12-01 → 2021-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.1bn | 2021-12-01 → 2022-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.0bn | 2020-12-01 → 2021-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥606m | 2021-12-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.7bn | 2020-12-01 → 2021-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.1bn | 2020-12-01 → 2021-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥601m | 2021-12-01 → 2022-08-31 | Cons. | Profit loss |
| Net income | ¥1.1bn | 2020-12-01 → 2021-08-31 | Cons. | Profit loss |
| Total assets | ¥62.9bn | at 2022-08-31 | Cons. | Assets |
| Total assets | ¥63.6bn | at 2021-11-30 | Cons. | Assets |
| Total assets | ¥62.0bn | at 2021-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥35.7bn | at 2022-08-31 | Cons. | Liabilities |
| Total liabilities | ¥36.5bn | at 2021-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥27.1bn | at 2022-08-31 | Cons. | Net assets |
| Net assets / equity | ¥27.0bn | at 2021-11-30 | Cons. | Net assets |
| Net assets / equity | ¥26.5bn | at 2021-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.2bn | at 2022-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.9bn | at 2021-11-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥15.17 | 2021-12-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.19 | 2022-06-01 → 2022-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.86 | 2020-12-01 → 2021-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.2 | 2020-12-01 → 2021-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.94 | 2021-06-01 → 2021-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥46.63 | 2020-12-01 → 2021-11-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.99 | 2020-12-01 → 2021-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 43.0% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2021-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.8% | at 2021-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 58
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-12-01 → 2022-08-31 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-12-01 → 2022-08-31 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-12-01 → 2022-08-31 | −¥29m |
| Reconciling Itemsreconciling | revenue | 2021-12-01 → 2022-08-31 | −¥944m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-12-01 → 2022-08-31 | −¥944m |
| Reconciling Itemsreconciling | segment profit | 2021-12-01 → 2022-08-31 | ¥119m |
| jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segment | revenue | 2021-12-01 → 2022-08-31 | ¥11.5bn |
| jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-08-31 | ¥11.1bn |
| jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-08-31 | ¥438m |
| jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-08-31 | ¥169m |
| jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2021-12-01 → 2022-08-31 | ¥10.5bn |
| jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2021-12-01 → 2022-08-31 | ¥10.4bn |
| jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2021-12-01 → 2022-08-31 | ¥105m |
| jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2021-12-01 → 2022-08-31 | −¥92m |
| jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segment | revenue | 2021-12-01 → 2022-08-31 | ¥6.5bn |
| jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-08-31 | ¥6.5bn |
| jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-08-31 | ¥70m |
| jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-08-31 | −¥130m |
| jpcrp040300-q3r_E02585-000Medicalreportable segment | revenue | 2021-12-01 → 2022-08-31 | ¥9.3bn |
| jpcrp040300-q3r_E02585-000Medicalreportable segment | revenue external | 2021-12-01 → 2022-08-31 | ¥8.9bn |
| jpcrp040300-q3r_E02585-000Medicalreportable segment | revenue intersegment | 2021-12-01 → 2022-08-31 | ¥331m |
| jpcrp040300-q3r_E02585-000Medicalreportable segment | segment profit | 2021-12-01 → 2022-08-31 | ¥389m |
| —segment total | revenue | 2021-12-01 → 2022-08-31 | ¥37.9bn |
| —segment total | revenue external | 2021-12-01 → 2022-08-31 | ¥36.9bn |
| —segment total | revenue intersegment | 2021-12-01 → 2022-08-31 | ¥944m |
| —segment total | segment profit | 2021-12-01 → 2022-08-31 | ¥336m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-12-01 → 2022-08-31 | ¥37.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-12-01 → 2022-08-31 | ¥36.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-12-01 → 2022-08-31 | ¥944m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-12-01 → 2022-08-31 | ¥307m |
| Reconciling Itemsreconciling | revenue | 2020-12-01 → 2021-08-31 | −¥975m |
| Reconciling Itemsreconciling | revenue external | 2020-12-01 → 2021-08-31 | ¥36,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2020-12-01 → 2021-08-31 | −¥975m |
| Reconciling Itemsreconciling | segment profit | 2020-12-01 → 2021-08-31 | −¥48m |
| jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segment | revenue | 2020-12-01 → 2021-08-31 | ¥17.6bn |
| jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segment | revenue external | 2020-12-01 → 2021-08-31 | ¥17.0bn |
| jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2020-12-01 → 2021-08-31 | ¥669m |
| jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segment | segment profit | 2020-12-01 → 2021-08-31 | ¥1.0bn |
| jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2020-12-01 → 2021-08-31 | ¥20.9bn |
| jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2020-12-01 → 2021-08-31 | ¥20.8bn |
| jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2020-12-01 → 2021-08-31 | ¥29m |
| jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2020-12-01 → 2021-08-31 | −¥442m |
| jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segment | revenue | 2020-12-01 → 2021-08-31 | ¥6.3bn |
| jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2020-12-01 → 2021-08-31 | ¥6.2bn |
| jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2020-12-01 → 2021-08-31 | ¥45m |
| jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2020-12-01 → 2021-08-31 | ¥311m |
| jpcrp040300-q3r_E02585-000Medicalreportable segment | revenue | 2020-12-01 → 2021-08-31 | ¥9.9bn |
| jpcrp040300-q3r_E02585-000Medicalreportable segment | revenue external | 2020-12-01 → 2021-08-31 | ¥9.7bn |
| jpcrp040300-q3r_E02585-000Medicalreportable segment | revenue intersegment | 2020-12-01 → 2021-08-31 | ¥232m |
| jpcrp040300-q3r_E02585-000Medicalreportable segment | segment profit | 2020-12-01 → 2021-08-31 | ¥1.1bn |
| —segment total | revenue | 2020-12-01 → 2021-08-31 | ¥54.7bn |
| —segment total | revenue external | 2020-12-01 → 2021-08-31 | ¥53.7bn |
| —segment total | revenue intersegment | 2020-12-01 → 2021-08-31 | ¥975m |
| —segment total | segment profit | 2020-12-01 → 2021-08-31 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-12-01 → 2021-08-31 | ¥54.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-12-01 → 2021-08-31 | ¥53.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-12-01 → 2021-08-31 | ¥975m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-12-01 → 2021-08-31 | ¥2.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 452
| Item | Context | Value | Unit |
|---|---|---|---|
| Other cl | Prior1YearInstant | 978385000 | JPY |
| Other cl | CurrentQuarterInstant | 1580481000 | JPY |
| Current liabilities | Prior1YearInstant | 26639245000 | JPY |
| Current liabilities | CurrentQuarterInstant | 26842816000 | JPY |
| Long term loans payable | Prior1YearInstant | 5812500000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 4877500000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 936999000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 764450000 | JPY |
| Provision for share based compensation ncl | Prior1YearInstant | 66255000 | JPY |
| Provision for share based compensation ncl | CurrentQuarterInstant | 66255000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 2598896000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 2626000000 | JPY |
| Other ncl | Prior1YearInstant | 493480000 | JPY |
| Other ncl | CurrentQuarterInstant | 561505000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 9908132000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 8895712000 | JPY |
| Liabilities | Prior1YearInstant | 36547377000 | JPY |
| Liabilities | CurrentQuarterInstant | 35738528000 | JPY |
| Capital stock | Prior1YearInstant | 4528304000 | JPY |
| Capital stock | CurrentQuarterInstant | 4557400000 | JPY |
| Capital surplus | Prior1YearInstant | 6516607000 | JPY |
| Capital surplus | CurrentQuarterInstant | 6538828000 | JPY |
| Retained earnings | Prior1YearInstant | 15027322000 | JPY |
| Retained earnings | CurrentQuarterInstant | 15058299000 | JPY |
| Treasury stock | Prior1YearInstant | -254106000 | JPY |
| Treasury stock | CurrentQuarterInstant | -441100000 | JPY |
| Shareholders equity | Prior1YearInstant | 25818127000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 25713427000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 985867000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 1051846000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | -763000 | JPY |
| Deferred gains or losses on hedges | CurrentQuarterInstant | -787000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 103839000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 193192000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 92615000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 83835000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 1181558000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 1328086000 | JPY |
| Non controlling interests | Prior1YearInstant | 6586000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 82353000 | JPY |
| Net assets | Prior1YearInstant | 27006272000 | JPY |
| Net assets | CurrentQuarterInstant | 27123867000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 63553650000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 62862395000 | JPY |
| Net sales | Prior1YTDDuration | 53727608000 | JPY |
| Net sales | CurrentYTDDuration | 36928145000 | JPY |
| Cost of sales | Prior1YTDDuration | 41007825000 | JPY |
| Cost of sales | CurrentYTDDuration | 25256654000 | JPY |
| Gross profit | Prior1YTDDuration | 12719783000 | JPY |
| Gross profit | CurrentYTDDuration | 11671491000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |